5-HT2A and mGlu2/3 receptor interactions: on their relevance to cognitive function and psychosis

被引:21
作者
Wischhof, Lena [1 ]
Koch, Michael [1 ]
机构
[1] Univ Bremen, Dept Neuropharmacol, Ctr Cognit Sci, Brain Res Inst, D-28359 Bremen, Germany
来源
BEHAVIOURAL PHARMACOLOGY | 2016年 / 27卷 / 01期
关键词
hallucinogens; serotonin; receptor interactions; glutamate; antipsychotic drugs; behavioral function; schizophrenia; METABOTROPIC GLUTAMATE RECEPTORS; SCHIZOPHRENIA-LIKE ALTERATIONS; MEDIAL PREFRONTAL CORTEX; REACTION-TIME-TASK; PREPULSE INHIBITION; RAT-BRAIN; ANTIPSYCHOTIC-DRUGS; SEROTONIN RECEPTORS; IMPULSIVE BEHAVIOR; PYRAMIDAL CELLS;
D O I
10.1097/FBP.0000000000000183
中图分类号
B84 [心理学]; C [社会科学总论]; Q98 [人类学];
学科分类号
03 ; 0303 ; 030303 ; 04 ; 0402 ;
摘要
Serotonin [5-hydroxytryptamine (5-HT)] and glutamate have both been implicated in the pathophysiology of neuropsychiatric disorders but also in the mechanism of antipsychotic and hallucinogenic drug actions. Furthermore, close antagonistic interactions between 5-HT2A and metabotropic glutamate (mGlu)2/3 receptors have been established over the last decades on the basis of numerous electrophysiological, biochemical, and behavioral studies. Besides synaptic mechanisms, more recent findings suggested that heterodimeric 5-HT2A-mGlu2 receptor complexes in the prefrontal cortex may account for the functional crosstalk between these two receptor subtypes. In this review, we focus on in-vitro and in-vivo studies documenting the important relationship between 5-HT2A and mGlu2/3 receptors, with relevance to both normal behavioral function and psychosis.
引用
收藏
页码:1 / 11
页数:11
相关论文
共 108 条
[1]   Epigenetic dysregulation of HTR2A in the brain of patients with schizophrenia and bipolar disorder [J].
Abdolmaleky, Hamid Mostafavi ;
Yaqubi, Sahab ;
Papageorgis, Panagiotis ;
Lambert, Arthur W. ;
Ozturk, Sait ;
Sivaraman, Vadivelu ;
Thiagalingam, Sam .
SCHIZOPHRENIA RESEARCH, 2011, 129 (2-3) :183-190
[2]   A long-term, phase 2, multicenter, randomized, open-label, comparative safety study of pomaglumetad methionil (LY2140023 monohydrate) versus atypical antipsychotic standard of care in patients with schizophrenia [J].
Adams, David H. ;
Kinon, Bruce J. ;
Baygani, Simin ;
Millen, Brian A. ;
Velona, Isabella ;
Kollack-Walker, Sara ;
Walling, David P. .
BMC PSYCHIATRY, 2013, 13
[3]   Serotonin, via 5-HT2A receptors, increases EPSCs in layer V pyramidal cells of prefrontal cortex by an asynchronous mode of glutamate release [J].
Aghajanian, GK ;
Marek, GJ .
BRAIN RESEARCH, 1999, 825 (1-2) :161-171
[4]   Serotonin induces excitatory postsynaptic potentials in apical dendrites of neocortical pyramidal cells [J].
Aghajanian, GK ;
Marek, GJ .
NEUROPHARMACOLOGY, 1997, 36 (4-5) :589-599
[5]   BDNF in schizophrenia, depression and corresponding animal models [J].
Angelucci, F ;
Brenè, S ;
Mathé, AA .
MOLECULAR PSYCHIATRY, 2005, 10 (04) :345-352
[6]   A review of central 5-HT receptors and their function [J].
Barnes, NM ;
Sharp, T .
NEUROPHARMACOLOGY, 1999, 38 (08) :1083-1152
[7]   Mechanism of the 5-hydroxytryptamine 2A receptor-mediated facilitation of synaptic activity in prefrontal cortex [J].
Beique, Jean-Claude ;
Imad, Mays ;
Mladenovic, Ljiljana ;
Gingrich, Jay A. ;
Andrade, Rodrigo .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2007, 104 (23) :9870-9875
[8]   Enhanced Function of Prefrontal Serotonin 5-HT2 Receptors in a Rat Model of Psychiatric Vulnerability [J].
Benekareddy, Madhurima ;
Goodfellow, Nathalie M. ;
Lambe, Evelyn K. ;
Vaidya, Vidita A. .
JOURNAL OF NEUROSCIENCE, 2010, 30 (36) :12138-12150
[9]   A selective positive allosteric modulator of metabotropic glutamate receptor subtype 2 blocks a hallucinogenic drug model of psychosis [J].
Benneyworth, Michael A. ;
Xiang, Zixiu ;
Smith, Randy L. ;
Garcia, Efrain E. ;
Conn, P. Jeffrey ;
Sanders-Bush, Elaine .
MOLECULAR PHARMACOLOGY, 2007, 72 (02) :477-484
[10]   Habituation deficits induced by metabotropic glutamate receptors 2/3 receptor blockade in mice:: Reversal by antipsychotic drugs [J].
Bespalov, Anton ;
Jongen-Relo, Ana-Lucia ;
van Gaalen, Marcel ;
Harich, Silke ;
Schoemaker, Hans ;
Gross, Gerhard .
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2007, 320 (02) :944-950